Phase II study of EGFR-TKI in elderly patients with lung cancer harboring EGFR gene mutation in liquid biopsy
Phase 2
Recruiting
- Conditions
- on-small cell lung cancer
- Registration Number
- JPRN-UMIN000025624
- Lead Sponsor
- Respiratory Center. Asahikawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
Patients are excluded if they have; (1)Severe concomitant disease. (2)Severe history of hypersensitivity. (3)Severe heart disease or arrhythmia. (4)Interstitial pneumonia. (5)Active infection. (6)Active peptic ulcer. (7)Active double cancer. (8)No measurable lesion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate.
- Secondary Outcome Measures
Name Time Method Safety, progression free survival, overall survival.